CLENOLIXIMAB
UNII 78EVW7GX37

Substance Identification & Data

This profile provides standardized clinical and technical data for Clenoliximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 78EVW7GX37.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 182912-58-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

78EVW7GX37

CAS Registry Number

182912-58-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CLENOLIXIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C188527

National Cancer Institute reference terminology for clinical and research data.

INN ID

7615

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Clenoliximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CLENOLIXIMAB

Common Names & Synonyms

CLENOLIXIMAB [INN]

CLENOLIXIMAB [WHO-DD]

IMMUNOGLOBULIN G 4 (HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .GAMMA.4-CHAIN ANTI-HUMAN ANTIGEN CD 4), DISULFIDE WITH HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G 4 (HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .GAMMA.4-CHAIN ANTI-HUMAN ANTIGEN CD 4), DISULPHIDE WITH HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4, ANTI-(HUMAN CD4 (ANTIGEN)) (HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .LAMBDA.-CHAIN, DIMER